PREMA Preconception Medical Assessment: A Validated Tool to Assess Preconception Health Risk Outside the Health Care Setting [ID 1758]

INTRODUCTION: One in three women of reproductive age has a chronic disease, and on average only 30% to 50% receive a preconception visit. Identifying potential pregnancy risks before conception can enhance patients’ engagement in their health and alert providers to possible complications. Until now, there has not been a validated patient-initiated preconception screening. METHODS: PREMA, a seven-question assessment in English and Spanish, was derived from the Obstetric Comorbidity Index, a validated tool using a weighted point system. Higher scores indicate a higher risk for severe maternal morbidity and potential intensive care admission. PREMA assigns a score based on patients' health conditions. PREMA was developed through a modified Delphi process under the guidance of the California Perinatal Advisory Board, with IRB approval. RESULTS: A convenience sample of English- and Spanish-speaking participants was recruited online. The first 100 participants received a $10 gift card. In total, 223 respondents, including 125 Spanish and 98 English speakers, completed the survey. Most participants found the survey easy to complete, with 97% of Spanish and 89% of English speakers agreeing. CONCLUSIONS/IMPLICATIONS: PREMA is the first validated preconception medical assessment designed for completion outside a health care setting. Once completed, participants are categorized into high, moderate, or average pregnancy risk, and receive general health resources and recommendations. PREMA enables individuals to assess their health risks and initiate conversations with providers to reduce their pregnancy risk and improve their overall health.